Regenxbio (RGNX) Long-Term Investments (2014 - 2025)

Regenxbio's Long-Term Investments history runs 12 years deep, the most recent figure standing at $10.8 million for Q4 2025.

• In Q4 2025, Long-Term Investments rose 5.95% year-over-year to $10.8 million; the TTM figure through Dec 2025 stood at $10.8 million (up 5.95% YoY), while the FY2025 annual figure was $10.8 million, up 5.95% from the prior year.
• Long-Term Investments was $10.8 million for Q4 2025 at Regenxbio, down from $27.8 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $391.9 million in Q4 2021 to a low of $4.9 million in Q1 2025.
• Historically, Long-Term Investments has averaged $131.9 million across 5 years, with a median of $79.0 million in 2023.
• The sharpest annual moves came in 2021 and 2025: Long-Term Investments soared 737.25% in 2021, then tumbled 88.38% in 2025.
• A 5-year view of Long-Term Investments shows it stood at $391.9 million in 2021, then plunged by 48.82% to $200.6 million in 2022, then sank by 80.62% to $38.9 million in 2023, then plunged by 73.81% to $10.2 million in 2024, then increased by 5.95% to $10.8 million in 2025.
• The last three Long-Term Investments figures came in at $10.8 million (Q4 2025), $27.8 million (Q3 2025), and $40.3 million (Q2 2025), per Business Quant data.